Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.

Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.

The present study aimed to evaluate the side-effects and efficacy of thalidomide in combination with an anthracycline-containing chemotherapy regimen in previously untreated myeloma patients. Thalidomide (400 mg/d) was combined with bolus injections of vincristine and epirubicin and oral dexamethaso...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Schütt, P, Ebeling, P, Buttkereit, U, Brandhorst, D, Opalka, B, Hoiczyk, M, Flasshove, M, Hense, J, Bojko, P, Metz, K, Moritz, T, Seeber, S, Nowrousian, MR
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2005

Những quyển sách tương tự

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Bằng: Schütt, P, et al.
Được phát hành: (2005)

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Bằng: Schütt, P, et al.
Được phát hành: (2005)

Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
Bằng: Schütt, P, et al.
Được phát hành: (2006)

Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Bằng: Nowrousian, MR, et al.
Được phát hành: (2005)

The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Bằng: Schütt, P, et al.
Được phát hành: (2008)

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
Bằng: Rebmann, V, et al.
Được phát hành: (2007)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
Bằng: Juan M. Cano-Calderón, et al.
Được phát hành: (2025-01-01)

High dose Simvastatin does not reverse resistance to Vincristine, Adriamycin, and Dexamethasone (VAD) in Myeloma
Bằng: E. van der Spek, et al.
Được phát hành: (2007-12-01)

P21 EFFECTIVENESS AND SAFETY OF DELAYED BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE (VTD) REGIMEN
Bằng: V. Del Fabro, et al.
Được phát hành: (2023-05-01)

Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone
Bằng: Di Wang, et al.
Được phát hành: (2021-01-01)

Comparison of Two Therapeutic Regimes, Lenalidomide with Dexamethasone and Thalidomide with Dexamethasone, in the Treatment of Multiple Myeloma at a Tertiary Care Hospital in India
Bằng: Nithin Sashidharan, et al.
Được phát hành: (2015-05-01)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
Bằng: Edvan De Queiroz Crusoe, et al.
Được phát hành: (2020-04-01)

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
Bằng: Yin-Che Wang, et al.
Được phát hành: (2025-12-01)

A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone
Bằng: Jew Win Kuan, et al.
Được phát hành: (2022-01-01)

The efficacy and tolerability of bortezomib, thalidomide, and dexamethasone induction therapy with a thalidomide dose step‐up strategy in patients with newly diagnosed multiple myeloma: A prospective observational study
Bằng: Po‐Wei Liao, et al.
Được phát hành: (2024-05-01)

Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
Bằng: Taleb Azarm, et al.
Được phát hành: (2012-01-01)

Altered Regional Brain Glucose Metabolism in Diffuse Large B-Cell Lymphoma Patients Treated With Cyclophosphamide, Epirubicin, Vincristine, and Prednisone: An Fluorodeoxyglucose Positron Emission Tomography Study of 205 Cases
Bằng: Yuxiao Hu, et al.
Được phát hành: (2022-06-01)

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
Bằng: Laura Rosiñol, et al.
Được phát hành: (2023-11-01)

Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
Bằng: Buxant F, et al.
Được phát hành: (2017-03-01)

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial
Bằng: Martin Kropff, et al.
Được phát hành: (2012-05-01)

Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
Bằng: Suhailur Rehman, et al.
Được phát hành: (2017-07-01)

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial
Bằng: Karthik Ramasamy, et al.
Được phát hành: (2022-11-01)

Thalidomide in treatment of connective diseases and vasculities
Bằng: D. Ribatti, et al.
Được phát hành: (2011-09-01)

Nanoparticle Effect on Interaction of Epirubicin with DNA
Bằng: Leyla Karadurmus, et al.
Được phát hành: (2017-11-01)

P1067: PHASE 2 STUDY OF ORAL THALIDOMIDE-CYCLOPHOSPHAMIDE-DEXAMETHASONE FOR RECURRENT/REFRACTORY ADULT LANGERHANS CELL HISTIOCYTOSIS
Bằng: J.-N. Wang, et al.
Được phát hành: (2022-06-01)

New therapies for heart failure: is thalidomide the answer?
Bằng: Davey, P, et al.
Được phát hành: (2000)

Thalidomide, the story goes on
Bằng: Esther Papaseit, et al.
Được phát hành: (2023-06-01)

Treatment of Aphthae with Thalidomide
Bằng: Mahmoud Farshchian
Được phát hành: (1994-03-01)

Thalidomide in dermatology: Revisited
Bằng: Iffat Hassan, et al.
Được phát hành: (2015-01-01)

Gammel Testamente ved Det Teologiske Fakultet ved Aarhus Universitet
Bằng: Hans J. Lundager Jensen
Được phát hành: (2009-09-01)

Genoptagelse ved hjælp af proformer ved simultantolkning fra tysk
Bằng: Friedel Dubslaff
Được phát hành: (2017-02-01)

Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study
Bằng: Patrice Chevallier, et al.
Được phát hành: (2015-04-01)

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
Bằng: Henk M. Lokhorst, et al.
Được phát hành: (2008-01-01)

Reaksjonene ved promillekjøring
Bằng: R. N. Torgersen
Được phát hành: (1984-05-01)

Straffutmålingsnivået ved voldsforbrytelser
Bằng: Georg Fr. Rieber-Mohn
Được phát hành: (1988-08-01)

Styring ved straff
Bằng: Nils Christie
Được phát hành: (2000-09-01)

Epidemiologi ved korsryggsmerter
Bằng: Dag Magnar Soldal
Được phát hành: (2008-01-01)

Studieplanlægning ved lægeuddannelserne
Bằng: Anne Mette Mørcke, et al.
Được phát hành: (2010-03-01)

Gaveøkonomi ved Nasjonalmuseet
Bằng: Ane Moe
Được phát hành: (2016-01-01)

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
Bằng: Javier Pérez Quiñones, et al.
Được phát hành: (2022-01-01)